Filed in archive
Diabetics' Device
, Notable
, Treatment
by Gloria Gamat on June 22, 2007
Once Encapsulation Systems' U-Strip™ Insulin Patch hits the market, it will be the first wearable, programmable and non-invasive drug delivery system for diabetics dependent on insulin.
Encapsulation Systems, Inc. - the maker of this novel insulin patch - showcases the U-Strip Insulin System at the American Diabetes Association 67th Annual Scientific Sessions, June 22-26, 2007, McCormick Place Convention Center, Chicago, Il on Booth Number 848.
According to Bruce K. Redding, Jr., President and CEO, Encapsulation Systems, based in Havertown, Pennsylvania:
"The U-Strip Insulin Patch is an ultrasonic drug delivery system using an alternating sonic transmission to effect pore dilation and deposit large molecule drugs into the dermis.
Although our primary market is Type 2 diabetics, our insulin delivery transdermal patch is able to deliver a basal and bolus dose of insulin under a programmable regimen to both Type 1 and Type 2 diabetics."
Currently, the U-Strip™ Insulin Patch is in Phase-2 clinical trials and not yet approved for human use by the FDA.
Find more details from MarketWire.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/77116
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for U-Strip(TM) Insulin Patch Previews at ADA Scientific Sessions:
|
Rating: 6.67 out of 6 vote(s) cast.
|
Response from:
smreddy
(11/08/08 7:49am)
Alternative dds seems nice. i am yet try to give comments
Response from:
smreddy
(11/08/08 7:54am)
--
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
